Albireo Pharma, Inc. announced the appointment of Simon Harford as Chief Financial Officer and Treasurer. Harford will succeed Tom Shea, who is stepping down from the role. Harford most recently was Chief Financial Officer at Parexel International Corporation, where he led the financial aspects of the transition from public to private-equity owned company and rebuilt the finance function.

Previously, Harford was SVP Finance, Global Pharmaceuticals at GlaxoSmithKline plc with global responsibility for finance across all regions. Overall, Harford's career spans more than 30 years including numerous senior leadership roles across finance and investor relations at GlaxoSmithKline plc., Avon Products, Inc. and Eli Lilly and Company both in the United States and internationally. Further strengthening the finance team, Albireo also recently hired John Dadurian CPA, MBA as Senior Director of Finance and Accounting.

Dadurian most recently was Finance Director at SCIEX, a $1 billion medical device manufacturer.